The P. D. Hinduja National Hospital and Medical Research Centre is a multi-specialty, tertiary care hospital in Mumbai, India. It was founded by Parmanand Deepchand Hinduja, in collaboration with the Massachusetts General Hospital, the main teaching hospital of Harvard Medical School, Boston.

There are 400 beds in PD Hinduja Hospital.

During the past decade, PD Hinduja Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PD Hinduja Hospital" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Bayer" with 1 trials sponsored and "BioMérieux" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PD Hinduja Hospital" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Burnet Institute" with 1 trials as a collaborator, "Centre for Research in Intensive Care (CRIC)" with 1 trials as a collaborator and "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "PD Hinduja Hospital" are "Dyslipidemia" (4 trials), "Hypercholesterolemia" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Type II Diabetes Mellitus" (2 trials) and "Active Tuberculosis" (1 trials). Many other conditions were trialed in "PD Hinduja Hospital" in a lesser frequency.

Most popular intervention types in "PD Hinduja Hospital" are "Drug" (19 trials), "Diagnostic Test" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Pitavastatin" (4 trials), "Atorvastatin" (3 trials), "Nintedanib" (2 trials) and "Blood draw and IGRA test" (1 trials). Other intervention names were less common.

The vast majority of trials in "PD Hinduja Hospital" are 25 trials for "All" genders.

Currently, there are NaN active trials in "PD Hinduja Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in PD Hinduja Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in PD Hinduja Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

PD Hinduja Hospital has several departments that took part in Clinical trials: "P D Hinduja National Hospital and Medical Research Centre/ Pulmunory Medicine" - 2 trials